Epstein Barr Virus External Quality Assessment
The RIQAS Epstein Barr Virus (infectious mononucleosis) EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.
- Liquid ready-to-use
- 100% human Plasma
- Quarterly reporting (3 samples per quarterly distribution)
- Submit results and view reports online via RIQAS.Net
- Suitable for both quantitative and qualitative methods of analysis
Not accredited to ISO/IEC 17043
*Please note, that as of July 2021 (Cycle 10), there will be some exciting changes to the format of this programme. From July 2021, this programme will move to a monthly reporting format and will be distributed twice per year. There will be 1 sample to run each month, totaling 12 over the full cycle.*
- Anti-EBNA IgG
- Anti-EBV VCA IgG
- Anti-EBV VCA IgM
Please note, product availability may vary country to country.